Conference Agenda
Overview and details of the sessions of this conference. Please select a date or location to show only sessions at that day or location. Please select a single session for detailed view (with abstracts and downloads if available).
|
Session Overview | |
Location: ETH E27 D-BSSE, ETH, 84 seats |
Date: Monday, 25/Aug/2025 | |
11:30am - 1:00pm |
Causal inference - dealing with bias Location: ETH E27 Proximal indirect comparison Selection bias of cause-specific hazard ratios: the impact of competing events qbaconfound: A flexible Monte Carlo probabilistic bias analysis to unmeasured confounding Selection bias due to omitting interactions from inverse probability weighting External reproduction of a proxy-based causal model estimating average survival effects of sequential vs concurrent chemo-radiotherapy in stage III NSCLC |
2:00pm - 3:30pm |
Meta-analysis 1 Location: ETH E27 Precision Of Treatment Hierarchy: A Metric for Quantifying Certainty in Treatment Hierarchies from Network Meta-Analysis Extending P-Scores for Ranking Diagnostic Tests in Network Meta-Analysis Resolving conflicting treatment hierarchies across multiple outcomes in multivariate network meta-analysis A novel approach for modelling components of complex interventions in network meta-analysis The impact of using different random effects models in meta-analysis |
4:00pm - 5:30pm |
Bayesian methods 1 Location: ETH E27 A Bayesian model for surrogate endpoint evaluation in mixed biomarker patient populations Extending Bayesian Causal Forests for Longitudinal Data Analysis: A Case Study in Multiple Sclerosis A Bayesian framework for measuring the information cost of interim decisions in group sequential trials Bayesian semiparametric modelling of biomarker variability in joint models for longitudinal and survival data Bayesian analysis of the causal reference-based model for missing data in clinical trials |
Date: Tuesday, 26/Aug/2025 | |
9:15am - 10:45am |
Infectious disease modelling Location: ETH E27 Flexible parametric additive hazards regression for modeling excess mortality in pandemics Parameter Estimation in Compartmental Epidemic Models with Heterogeneity in Susceptibility Unobserved intermediate events in multi-state models in a pandemic setting Controlled vaccine efficacy using a joint model for sparse immunological data and time-to-disease. Infectious Disease Estimands That Are Insensitive to Interference |
11:30am - 1:00pm |
Meta-analysis 2 Location: ETH E27 How to quantify between-study heterogeneity in single-arm evidence synthesis Bayesian random-effects meta-analysis with empirical heterogeneity priors for HTA applications in the situation of very few studies Assessing inconsistency in flexible meta-regression using network meta analysis Illuminating the Assumptions of Meta-Regression in Treatment Networks Transitivity in Network Meta-Analysis: A Formal Framework and Practical Implications |
Date: Wednesday, 27/Aug/2025 | |
9:00am - 10:30am |
Prediction / prognostic modelling 3 Location: ETH E27 Predicting Prediction Performance Predictive modelling with block missingness Lifestyle Predictors of All-Cause Mortality: Enhancing Risk Models Beyond Traditional Biomarkers Development and validation of the Options model, a clinical prediction model predicting risk of emergency caesarean births in nulliparous women Optimizing Dynamic Predictions from Joint Models using Super Learning |
2:00pm - 3:30pm |
Innovation in oncology dose escalation trials and beyond Location: ETH E27 Declaring Doses as Safe in Ongoing Oncology Dose-Escalation Trials: Are They Truly Safe? A Critical Assessment of Safety Criteria Guiding Phase I Dose Escalation for Modern Oncology Therapies: Tackling (Informative) Dropout with Bayesian Multi-Cycle Time-to-Event Models Potential Responses and the Order of Patient Inclusion in Early-Phase Sequential Trials. How best to allocate backfill patients in dose-finding oncology trials: a methodological review & simulation studies assessing best performance Dose optimisation in early phase oncology trials - backfill and expansion cohorts |
4:00pm - 5:30pm |
Prediction / prognostic modelling 4 Location: ETH E27 Adapting existing sample size calculations for developing risk prediction models to control for model stability Optimal Methods for Handling Continuous Predictors in Clinical Prediction Model Development: Balancing Flexibility and Stability Do Stable Performance Metrics Guarantee Stable Model Predictions? The Imbalance Dilemma: Can Class Imbalance Corrections Stabilize Clinical Prediction Models? Prediction with Logistic Regression in Binary Class Imbalance: comparing re-sampling techniques with threshold probability assignment under varying predictive covariates |
Contact and Legal Notice · Contact Address: Privacy Statement · Conference: ISCB46 |
Conference Software: ConfTool Pro 2.6.154+TC © 2001–2025 by Dr. H. Weinreich, Hamburg, Germany |